The DEA has recently endorsed a new, simplified two-step test for determining the accepted medical use of cannabis. This shift from the previous five-part criteria could significantly impact the potential rescheduling of marijuana from Schedule I to Schedule III.
Key developments:
New test focuses on two questions about medical treatment use
Department of Justice proposed rescheduling marijuana to Schedule III in May 2024.
The new two-step test for determining cannabis’ accepted medical use asks:
Whether licensed healthcare providers currently use the substance in medical treatments within legally authorized jurisdictions.
Whether there is credible scientific support for at least one medical condition treated with the substance.
This simplified test replaces the DEA’s previous five-part evaluation and is seen as a key factor in the ongoing cannabis rescheduling debate.
Rescheduling would subject marijuana to different regulatory controls
What are your thoughts on these changes? How might they affect the cannabis industry and healthcare sectors?
hashtag#CannabisPolicy hashtag#Healthcare hashtag#Regulation
🌐 Sources
linkedin.com – Thoughts on the Proposal to Change Marijuana …
klgates.com
– Here We Go Again: DOL Proposes New Fiduciary Rule | HUB
justice.gov
– Justice Department Submits Proposed Regulation to …
linkedin.com – Alicia Wallace’s Post
benzinga.com
– DEA Endorses New, Simplified Test To Determine …
mwe.com
– DOJ Proposes to Reschedule Marijuana (Cannabis) …